Citadel Advisors Llc Rotates From Crowded AI to Durable Cash Engines

The standout statement this quarter is the move in IVV: ramped to 1.88% of the book, up +5363.9% in shares and about $2.60B in capital. That is not a tweak; it is a deliberate grab for broad U.S. equity beta at a moment when stock-picking alone delivered a negative quarter.

Within tech, they are very clearly rotating inside the AI complex rather than abandoning it. Micron is up +50.6% in shares and roughly $521.7M in value, and Taiwan Semi is up +34.9%, together signaling a preference for memory and foundry capacity over the most crowded GPU leader. Cloudflare’s +444.3% share jump and ~$327.0M add shows appetite for networked infrastructure that benefits from AI traffic without being priced like a pure-play.

In platforms, Meta’s position more than doubled (+128.6% shares, ~$588.9M added) despite being modestly underwater versus their average cost. That looks like a high-conviction average-down on a core ad and social asset.

Citadel is also leaning hard into consumer and financial cash flow franchises:

• Warner Bros. Discovery: +149.4% in shares and about $483.3M more capital, a major bet on a beaten-up streaming and IP platform.
• Electronic Arts: +202.9% in shares, ~$397.5M added, expressing confidence in recurring gaming economics.
• Tesla: +134.8% shares, ~$446.5M add, reframing it more as a scaled industrial and software platform than a speculative EV story.
• Mastercard and MSCI: both aggressively increased, with Mastercard alone seeing a +516.1% share jump and ~$471.2M added, signaling conviction in fee-based, asset-light payment and index-licensing rails.
• Defensive growth and staples: Constellation Brands up +376.8% in shares (~$439.7M added), Waste Connections up +200.9%, and Coca-Cola and CVS both up +50.7%, as Citadel builds an income- and pricing-power ballast under the book.

The sells are as telling as the buys: Citadel is methodically de-crowding its biggest market darlings and harvesting gains to fund new bets.

The largest dollar trim is Amazon: shares cut -42.7%, freeing about $1.26B. Nvidia, still the top single-name position at 2.31% of the book, was pared by -13.4% (about $504.8M), and Applied Materials was slashed -47.9% (around $404.9M). Combined, that’s a clear signal they see better risk/reward in second-derivative AI plays than in the marquee leaders that now trade at rich expectations.

Microsoft and Alphabet’s GOOGL line were both gently reduced (Microsoft -19.2% in shares, GOOGL -2.7%), consistent with a soft de-risking across mega-cap software rather than a wholesale exit. The GOOG line, by contrast, is still being built (+4.0% shares), implying fine-tuning rather than a macro call on search and cloud.

In health care, the pattern is rotation, not abandonment. UnitedHealth and Merck both saw roughly -44% to -47% share reductions (about $375.0M and $360.9M trimmed respectively), while Citadel added to Gilead, Cardinal Health, and especially Johnson & Johnson (+146.0% shares, ~$280.1M more). They are swapping high-multiple managed care and mature pharma exposure into diversified pharmas and distributors with more balanced policy risk.

Financials tell a similar story. Morgan Stanley’s position was cut almost in half (-44.5% shares, about $378.1M out), while JPMorgan (+87.0% in shares, +$332.8M) and Citigroup (+34.1%, +$131.1M) were scaled up. Capital is leaving fee-heavy wealth and trading toward universal banks with deposit franchises and rate leverage.

Even in cyclicals and consumer, they are pruning around the edges: Home Depot (-16.3% shares), Costco (-11.4%), Ross Stores (-20.8%), and a small trim in O’Reilly suggest a willingness to take profits in long-run winners to underwrite newer, higher-upside ideas in media, gaming, and restaurants.

Despite the trims, this is still a tech-first book: technology sits near the high-30s as a percentage of the top-50 and only edged down a few points. The mix inside that allocation changed meaningfully, though – less Nvidia, Microsoft, and Applied Materials, more Micron, Taiwan Semi, Cloudflare, and GE Aerospace – a tilt from AI narrative winners toward the physical and network infrastructure that enables them.

Consumer Discretionary weight slipped a few points even as the number of discrete bets stayed rich. That’s because Amazon, Costco, Ross, and Home Depot were cut, while adds went into smaller lines like Warner Bros. Discovery, EA, FedEx, YUM, and Spotify. The sector is being remixed from U.S. retail behemoths into experience, content, and logistics platforms.

Health care’s share of the book declined from the low double-digits to the high single-digits as UnitedHealth, Merck, and Elevance were trimmed. Yet Citadel raised stakes in Intuitive Surgical (+30.3% shares), Thermo Fisher (+25.2%), J&J, Gilead, and Cardinal Health, suggesting a rotation toward devices, tools, and diversified pharma rather than a simple “short health care” call.

The biggest relative winners in allocation terms are the quasi-defensive and income-oriented buckets. Consumer Staples nearly doubled in weight as Constellation Brands, Coca-Cola, and CVS were all increased. Real-estate–classified names (here, effectively financial infrastructure via Mastercard and MSCI) and Telecom via T-Mobile also grew sharply, alongside Waste Connections in Utilities, which is really an environmental services cash-flow compounder.

Finally, the unclassified bucket surged as IVV and Berkshire Hathaway were built up. That is a quiet but important nod toward diversification and index exposure, letting Citadel lean less on idiosyncratic mega-cap tech to drive returns.

Taken together, this 13F paints the picture of a manager that still believes in the AI and U.S. growth story, but wants to be paid through memory, foundries, networks, and cash-flow machines rather than the most crowded front-page winners.

Massive additions to IVV, alongside larger positions in banks, payments, staples, and environmental services, suggest Citadel expects equities to work over time but is less willing to stake that view on a handful of tech titans. The top-10 concentration at 11.6% is low for an equity manager of this scale, underscoring a preference for breadth over concentration this quarter.

Within growth, they are favoring platforms with recurring economics – Meta, EA, Warner Bros. Discovery, Tesla, YUM, and Spotify – over pure volume stories like big-box retail. Within defensives, they are layering in beverages, drug distributors, diversified pharma, and military/aerospace names like Lockheed and Parker-Hannifin to buffer any macro stumble.

If the AI trade stays hot, their exposure via Micron, Taiwan Semi, Nvidia (still a large line), Cloudflare, and Alphabet should keep them participating. If it cools or corrects, the expanded ballast in IVV, banks, staples, and utilities-like franchises offers downside mitigation.

The next few quarters will show whether this shift from “hero names” to “plumbing and platforms” was early or prescient. For now, the message is clear: Citadel is still long innovation, but it is increasingly insisting on durable cash flows, index beta, and more balanced sector risk to carry that bet.